Home
About
Publications Trends
Recent Publications
Expert Search
Archive
minimally invasive surgeries
What are the Benefits of Minimally Invasive Surgeries?
The benefits of MIS in cancer treatment are significant and include:
Reduced Pain
and discomfort post-surgery due to smaller incisions.
Shorter Hospital Stay
, allowing patients to return home sooner.
Faster Recovery Time
, enabling quicker return to normal activities.
Decreased Risk of Infection
due to smaller wounds.
Less Scarring
compared to traditional open surgery.
Frequently asked queries:
What are Minimally Invasive Surgeries?
Why are Minimally Invasive Surgeries Important in Cancer Treatment?
What are the Benefits of Minimally Invasive Surgeries?
How to Determine if MIS is Suitable for a Patient?
What is the Prognosis for Cancer Patients with Musculoskeletal Pain?
What are the advancements in hormone therapy for cancer?
What Are the Implications for Clinical Trials?
Which Types of Cancer are Most Commonly Associated with Internal Bleeding?
What Are the Key Factors Influencing the EPR Effect?
What is Phosphoinositide 3 Kinase (PI3K)?
How Does HIPAA Affect Cancer Patients?
What Should Patients Communicate with Their Healthcare Team?
What Resources Are Available for Cancer Patients Struggling with Sleep?
Is There a Connection Between the Immune System and Both Conditions?
What Are Endocrine Glands?
How Can Community and Policy Interventions Help?
What are the Key Components of Cancer Facility Infrastructure?
What is Finasteride?
What Can Patients Expect During Therapy Sessions?
What Are the Limitations of Whole Exome Sequencing?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe